| Date Filed | Type | Description |
| 11/29/2017 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 31,491 shares
@ $41.12, valued at
$1.3M
Sold 177,807 shares
@ $40.51, valued at
$7.2M
|
|
| 07/20/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2016 |
4
| ProQuest Management LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Disposed of 4,770,828 shares
@ $0
Disposed of 9,360 shares
@ $0 |
|
| 05/16/2016 |
4
| ProQuest Management LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Sold 4,000 shares
@ $40, valued at
$160k
Sold 13,980 shares
@ $40.92, valued at
$572.1k
|
|
| 01/29/2016 |
4
| Moorin Jay (10% Owner) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Bought 393,700 shares
@ $6.35, valued at
$2.5M
|
|
| 01/14/2016 |
4
| Moorin Jay (Director) has filed a Form 4 on Arno Therapeutics, Inc|
Txns:
| Granted 88,648 options to buy
@ $0.3, valued at
$26.6k
|
|
| 01/05/2016 |
4
| Moorin Jay (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $86.15, valued at
$1.3M
|
|
| 07/02/2015 |
4
| ProQuest Management LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Disposed of 2,970 shares
@ $0 |
|
| 05/13/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 22,607 shares
@ $22.26, valued at
$503.2k
Sold 155,000 shares
@ $21.5, valued at
$3.3M
|
|
| 05/07/2015 |
4
| ProQuest Management LLC (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Disposed of 9,903 shares
@ $0 |
|
| 04/24/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 25,249 shares
@ $26.56, valued at
$670.6k
Sold 10,000 shares
@ $26.64, valued at
$266.4k
Sold 22,643 shares
@ $27.35, valued at
$619.3k
Sold 25,000 shares
@ $26.64, valued at
$666k
|
|
| 04/22/2015 |
4
| Moorin Jay (10% Owner) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $59.31, valued at
$593.1k
|
|
| 04/21/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 18,861 shares
@ $26.67, valued at
$503k
Sold 12,792 shares
@ $26.44, valued at
$338.2k
Sold 14,167 shares
@ $26.35, valued at
$373.3k
|
|
| 04/16/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 13,814 shares
@ $27.26, valued at
$376.6k
Sold 39,900 shares
@ $28.57, valued at
$1.1M
Sold 100 shares
@ $29.17, valued at
$2.9k
Sold 100 shares
@ $26.75, valued at
$2.7k
|
|
| 04/08/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 3,895 shares
@ $26.88, valued at
$104.7k
Sold 3,600 shares
@ $26.55, valued at
$95.6k
|
|
| 04/02/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 14,600 shares
@ $25.51, valued at
$372.4k
Sold 39,819 shares
@ $26.55, valued at
$1.1M
Sold 8,035 shares
@ $27.07, valued at
$217.5k
|
|
| 03/26/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 13,200 shares
@ $27.67, valued at
$365.2k
Sold 4,956 shares
@ $27.56, valued at
$136.6k
|
|
| 03/23/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 29,800 shares
@ $27.55, valued at
$821k
Sold 200 shares
@ $28.07, valued at
$5.6k
Sold 8,780 shares
@ $27.1924, valued at
$238.7k
Sold 200 shares
@ $28.04, valued at
$5.6k
Sold 400 shares
@ $28.13, valued at
$11.3k
Sold 84 shares
@ $28.15, valued at
$2.4k
Sold 5,000 shares
@ $27.78, valued at
$138.9k
|
|
| 03/18/2015 |
4
| ProQuest Investments IV, L.P. (10% Owner) has filed a Form 4 on Immune Design Corp.|
Txns:
| Sold 10,309 shares
@ $25.43, valued at
$262.2k
Sold 20,000 shares
@ $25.94, valued at
$518.8k
Sold 19,300 shares
@ $26.56, valued at
$512.6k
Sold 100 shares
@ $27.04, valued at
$2.7k
Sold 500 shares
@ $26.99, valued at
$13.5k
Sold 100 shares
@ $27.02, valued at
$2.7k
|
|
|